疾病修饰疗法对神经肌肉疾病患者呼吸功能的影响
1Division of Respiratory Medicine, British Columbia Children's Hospital, 4480 Oak Street, Room 1C31A, Vancouver, British Columbia, V6H 3V4, Canada; University of British Columbia, Vancouver, Canada.
新的疗法正在改变对脊柱肌缩 (SMA) 和杜申肌缩 (DMD) 的护理. 本综述侧重于这些进展如何影响这些神经肌肉疾病患者的呼吸功能.
科学领域:
- 神经学 神经学
- 肺部病理学 肺部病理学
- 遗传学 遗传学 是一个
背景情况:
- 脊柱肌缩 (SMA) 和杜申肌缩 (DMD) 是一种渐进的神经肌肉疾病.
- 呼吸道并发症是SMA和DMD的发病率和死亡率的主要原因.
- 由于新的治疗干预措施,当前的护理范式正在发生转变.
研究的目的:
- 在过去的十年中,审查SMA和DMD治疗的进展.
- 专注于疾病修饰疗法对呼吸功能的影响.
- 提供对不断变化的患者和护理人员体验的概述.
主要方法:
- 关于SMA和DMD治疗的最新研究的文献综述.
- 对临床试验数据的分析,重点关注呼吸道结果.
- 综合关于疾病修饰治疗的信息.
主要成果:
- 疾病修饰疗法已经显示出改变SMA和DMD轨迹的潜力.
- 新兴的治疗方法正在影响呼吸系统的结果,包括肺功能和呼吸模式.
- 治疗和患者护理的格局正在迅速发展.
结论:
- 治疗方面的进步为SMA和DMD患者提供了新的希望.
- 了解这些疗法对呼吸系统的影响对于优化患者护理至关重要.
- 持续的研究对于进一步改善神经肌肉疾病患者的结果至关重要.
更多相关视频
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
00:07Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
相关概念视频
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
